Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.
Naser Moghadasi A, Ashtari F, Baghbanian SM, Shaygannejad V, Anjidani N, Ghadiri F, Sedighi B, Saeidi M, Amirifard H, Ayromlou H, Beladi Moghadam N, Ranjbar MB, Nazeri M, Niknam Z, Faraji F, Afsorde A, Sahraian MA.
Naser Moghadasi A, et al. Among authors: saeidi m.
Arch Iran Med. 2023 Nov 1;26(11):647-653. doi: 10.34172/aim.2023.95.
Arch Iran Med. 2023.
PMID: 38310425
Free PMC article.
Clinical Trial.